IMPACT OF SUBSIDY ON THE USE OF PERSONALIZED MEDICINE IN BREAST CANCER

Advances in adjuvant therapy have led to increased survival rates after cancer prognosis. Herceptin, a targeted therapy, had first been introduced to Singapore in 2006. We aimed to assess whether subsidies for Herceptin from 2012 will lead to changes in uptake among Human Epidermal Growth Factor Rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cynthia, Lim, Jue Tao, Lim, Swee Ho, Tan, Ern Yu, Tan, Veronique Kiak Mien, Tan, Su Ming, Tan, Tira, Hartman, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770665/
http://dx.doi.org/10.1093/geroni/igac059.851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770665/
http://dx.doi.org/10.1093/geroni/igac059.851

Ejemplares similares